News and Events Highlights
CEEZAD is a public source for the latest information on developments related to high-consequence foreign animal, emerging and zoonotic disease threats.
February 18, 2026
'A silent symphony’
How Juergen Richt conducts a team tackling the world’s emerging animal diseases
February 9, 2025
Article explores dynamics of H5N1 clade 2.3.4.4b infection in calves and cows
An article co-authored by the Director of the Center of Excellence for Emerging and Zoonotic Animal Diseases (www.ceezad.org) and the Center on Emerging and Zoonotic Infectious Diseases CEZID examines the dynamics of the spread of H5N1 clade 2.3.4.4b in experimentally infected calves and cows.
February 5, 2025
CEEZAD study finds that pigs can transmit Mpox to sentinel animals
An article co-authored by the Director of the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD, www.ceezad.org) and the Center on Emerging and Zoonotic Infectious Diseases (CEZID; https://www.k-state.edu/cezid/) reports on findings concerning the transmission and susceptibility of the Mpox virus in a domestic livestock species.
CEEZAD study explores immune responses against SARS-CoV-2 in bison, elk and other captive wildlife species
An article co-authored by the Director of the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD, www.ceezad.org) and the Center on Emerging and Zoonotic Infectious Diseases (CEZID; https://www.k-state.edu/cezid/) examines immune responses against the SARS-CoV-2 virus in bison, elk and other captive wildlife species.
CEEZAD study finds Use of the Invariant Natural Killer T Cell Agonist α-Galactosylceramide as Adjuvant Can Lead to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs
An article co-authored by the Director of the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD, www.ceezad.org) and the Center on Emerging and Zoonotic Infectious Diseases (CEZID; https://www.k-state.edu/cezid/) discusses findings of recent research linking a Natural Killer T (NKT) cell agonist to enhanced respiratory disease in influenza-vaccinated pigs.